Mdm-2 Inhibits the G1 Arrest and Apoptosis Functions of the P53 Tumor Suppressor Protein

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1996 May 1

PMID 8628312

Citations 112

Authors

J Chen

X Wu

J Lin

A J Levine

Affiliations

Soon will be listed here.

Abstract

The mdm-2 gene encodes a 90-kDa polypeptide that binds specifically to the p53 tumor suppressor protein. This physical interaction results in the inhibition of the transcriptional functions of p53 (J. Chen, J. Lin, and A. J. Levine, Mol. Med. 1:142-152, 1995, and J. Momand, G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine, Cell 69:1237-1245, 1992). Experiments are described that demonstrate the ability of mdm-2 to abrogate both the p53-mediated cell cycle arrest and the apoptosis functions. In addition, the results presented here suggest that mdm-2 binding to p53 and the resultant inhibition of p53 transcription functions are critical for reversing p53-mediated cell cycle arrest. The N-terminal half or domain of the mdm-2 protein is sufficient to regulate these biological activities of p53, consistent with the possibility that the highly conserved central acidic region and the C-terminal putative zinc fingers of mdm-2 may encode other functions.

Citing Articles

Complex p53 dynamics regulated by miR-125b in cellular responses to reactive oxidative stress and DNA damage.

Malik M, Dashti M, Jangid A, Channanath A, John S, Brojen Singh R Brief Bioinform. 2025; 26(1.

PMID: 39820247 PMC: 11736902. DOI: 10.1093/bib/bbae706.

The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53.

Gottig L, Jummer S, Staehler L, Groitl P, Karimi M, Blanchette P J Virol. 2024; 98(4):e0170123.

PMID: 38451084 PMC: 11019960. DOI: 10.1128/jvi.01701-23.

A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle.

Li H, Dong L, Jin M, Li Q, Wang X, Jia M Molecules. 2023; 28(3).

PMID: 36770809 PMC: 9920120. DOI: 10.3390/molecules28031141.

ZLM-7 Blocks Breast Cancer Progression by Inhibiting MDM2 via Upregulation of 14-3-3 Sigma.

Wen M, Zou Z, Luo T, Li X, Liu S, Li J Pharmaceuticals (Basel). 2022; 15(7).

PMID: 35890172 PMC: 9321038. DOI: 10.3390/ph15070874.

High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma.

Schulze A, Kuntze A, Schmidt L, Mohr M, Marra A, Hillejan L Cancers (Basel). 2022; 14(6).

PMID: 35326547 PMC: 8946072. DOI: 10.3390/cancers14061395.

References

Francke U, GEORGE D . Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet. 1987; 13(3):235-44. DOI: 10.1007/BF01535205. View

Oliner J, Pietenpol J, Thiagalingam S, Gyuris J, Kinzler K, Vogelstein B . Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature. 1993; 362(6423):857-60. DOI: 10.1038/362857a0. View

Fields S, Jang S . Presence of a potent transcription activating sequence in the p53 protein. Science. 1990; 249(4972):1046-9. DOI: 10.1126/science.2144363. View

Raycroft L, Wu H, Lozano G . Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science. 1990; 249(4972):1049-51. PMC: 2935288. DOI: 10.1126/science.2144364. View

Diller L, Kassel J, Nelson C, Gryka M, Litwak G, Gebhardt M . p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol. 1990; 10(11):5772-81. PMC: 361354. DOI: 10.1128/mcb.10.11.5772-5781.1990. View

Malkin D, Li F, Strong L, Fraumeni Jr J, Nelson C, Kim D . Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990; 250(4985):1233-8. DOI: 10.1126/science.1978757. View

Srivastava S, Zou Z, Pirollo K, Blattner W, Chang E . Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990; 348(6303):747-9. DOI: 10.1038/348747a0. View

Fakharzadeh S, Trusko S, GEORGE D . Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 1991; 10(6):1565-9. PMC: 452821. DOI: 10.1002/j.1460-2075.1991.tb07676.x. View

Hollstein M, Sidransky D, Vogelstein B, Harris C . p53 mutations in human cancers. Science. 1991; 253(5015):49-53. DOI: 10.1126/science.1905840. View

10.

Leach F, Tokino T, Meltzer P, Burrell M, Oliner J, Smith S . p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 1993; 53(10 Suppl):2231-4. View

11.

Wu X, Bayle J, Olson D, Levine A . The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 1993; 7(7A):1126-32. DOI: 10.1101/gad.7.7a.1126. View

12.

Chen J, Marechal V, Levine A . Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol. 1993; 13(7):4107-14. PMC: 359960. DOI: 10.1128/mcb.13.7.4107-4114.1993. View

13.

Olson D, Marechal V, Momand J, Chen J, Romocki C, Levine A . Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene. 1993; 8(9):2353-60. View

14.

El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4):817-25. DOI: 10.1016/0092-8674(93)90500-p. View

15.

Van den Heuvel S, Harlow E . Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 1993; 262(5142):2050-4. DOI: 10.1126/science.8266103. View

16.

Cordon-Cardo C, Latres E, Drobnjak M, Oliva M, Pollack D, Woodruff J . Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res. 1994; 54(3):794-9. View

17.

Chiou S, Rao L, White E . Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol. 1994; 14(4):2556-63. PMC: 358623. DOI: 10.1128/mcb.14.4.2556-2563.1994. View

18.

Miyashita T, Krajewski S, Krajewska M, Wang H, Lin H, Liebermann D . Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994; 9(6):1799-805. View

19.

Caelles C, Helmberg A, Karin M . p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 1994; 370(6486):220-3. DOI: 10.1038/370220a0. View

20.

Symonds H, Krall L, Remington L, Lowe S, Jacks T, Van Dyke T . p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell. 1994; 78(4):703-11. DOI: 10.1016/0092-8674(94)90534-7. View